Abstract：
BACKGROUND: Radiotherapy (RT) clinical trials allow patients to access cutting-edge innovative cancer treatments. Clinical Research Therapy Radiographers (CRRs) play an important role in the management and care of RT trial patients. The COVID-19 pandemic caused major disruption to RT trial delivery. Measures to mitigate COVID-19 risk continue to have an effect on patient contact and communication within cancer centres in the United Kingdom (UK). This study aimed to explore patient perspectives regarding their recent RT trial experience in Northern Ireland (NI), UK.
METHODS: A single centre service evaluation was conducted in NI. Patients who were recruited into a RT clinical trial from January 2020 to January 2023 were invited to participate. Surveys were posted to 50 participants in April 2023. Quantitative and qualitative data was captured and analysed using descriptive statistics and Braun and Clarke\'s six-step thematic analysis framework respectively. Ethical approval was obtained through Ulster University and the NHS Trust.
RESULTS: Forty-three of the 50 invited participants responded (86%). Forty-two respondents (79%) had a prostate cancer diagnosis. Forty-one (98%) participants indicated that CRRs were always approachable, polite and courteous and would recommend taking part in a RT trial to friends and family. Identified areas for improvement included aspects regarding consent and participant decision-making.
CONCLUSIONS: This study suggests that despite the implemented measures to suspend research and mitigate COVID-19 risk, patients remained highly satisfied with the quality of care that they received through their participation in RT trials.
CONCLUSIONS: The results of this service evaluation will facilitate maintenance and improvement of patient focused delivery of cancer trials within the host centre. This study builds on evidence highlighting the importance of the CRR role and role development for radiographers.
METHODS: A single centre service evaluation was conducted in NI. Patients who were recruited into a RT clinical trial from January 2020 to January 2023 were invited to participate. Surveys were posted to 50 participants in April 2023. Quantitative and qualitative data was captured and analysed using descriptive statistics and Braun and Clarke\'s six-step thematic analysis framework respectively. Ethical approval was obtained through Ulster University and the NHS Trust.
RESULTS: Forty-three of the 50 invited participants responded (86%). Forty-two respondents (79%) had a prostate cancer diagnosis. Forty-one (98%) participants indicated that CRRs were always approachable, polite and courteous and would recommend taking part in a RT trial to friends and family. Identified areas for improvement included aspects regarding consent and participant decision-making.
CONCLUSIONS: This study suggests that despite the implemented measures to suspend research and mitigate COVID-19 risk, patients remained highly satisfied with the quality of care that they received through their participation in RT trials.
CONCLUSIONS: The results of this service evaluation will facilitate maintenance and improvement of patient focused delivery of cancer trials within the host centre. This study builds on evidence highlighting the importance of the CRR role and role development for radiographers.
摘要：
背景：放射治疗（RT）临床试验允许患者获得尖端创新的癌症治疗。临床研究治疗放射技师（CRR）在RT试验患者的管理和护理中起着重要作用。COVID-19大流行对RT试验交付造成了严重破坏。降低COVID-19风险的措施继续对英国(英国)癌症中心内的患者接触和沟通产生影响。这项研究旨在探索患者对他们最近在北爱尔兰（NI）的RT试验经验的看法。英国。
方法：在NI进行单中心服务评估。邀请从2020年1月至2023年1月参加RT临床试验的患者参加。2023年4月向50名参与者发布了调查。分别使用描述性统计和Braun和Clarke的六步主题分析框架捕获和分析了定量和定性数据。道德批准是通过阿尔斯特大学和NHS信托获得的。
结果：50名受邀参与者中有43名做出了回应（86%）。42名受访者（79％）诊断为前列腺癌。41名(98%)参与者表示CRR总是平易近人的，礼貌和礼貌，并建议参加RT试验给朋友和家人。确定的改进领域包括同意和参与者决策方面。
结论：这项研究表明，尽管采取了暂停研究和降低COVID-19风险的措施，患者对参与RT试验所获得的护理质量仍然非常满意.
结论：这项服务评估的结果将有助于在宿主中心内维持和改善以患者为中心的癌症试验交付。这项研究建立在强调CRR角色和角色发展对放射技师重要性的证据基础上。
方法：在NI进行单中心服务评估。邀请从2020年1月至2023年1月参加RT临床试验的患者参加。2023年4月向50名参与者发布了调查。分别使用描述性统计和Braun和Clarke的六步主题分析框架捕获和分析了定量和定性数据。道德批准是通过阿尔斯特大学和NHS信托获得的。
结果：50名受邀参与者中有43名做出了回应（86%）。42名受访者（79％）诊断为前列腺癌。41名(98%)参与者表示CRR总是平易近人的，礼貌和礼貌，并建议参加RT试验给朋友和家人。确定的改进领域包括同意和参与者决策方面。
结论：这项研究表明，尽管采取了暂停研究和降低COVID-19风险的措施，患者对参与RT试验所获得的护理质量仍然非常满意.
结论：这项服务评估的结果将有助于在宿主中心内维持和改善以患者为中心的癌症试验交付。这项研究建立在强调CRR角色和角色发展对放射技师重要性的证据基础上。
